Navigation Links
Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
Date:2/7/2008

RADNOR, Pa., Feb. 7 /PRNewswire/ -- The following release was issued today jointly by Schiffrin Barroway Topaz & Kessler, LLP and Milberg Weiss LLP:

UNITED STATES DISTRICT COURT

DISTRICT OF MARYLAND

(NORTHERN DIVISION)

IN RE MARTEK BIOSCIENCES CORP. (Ticker: MATK) SECURITIES LITIGATION

Civil Action No. MJG 05-1224

SUMMARY NOTICE OF PROPOSED SETTLEMENT AND SETTLEMENT HEARING

TO: ALL PERSONS AND ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED MARTEK BIOSCIENCES CORPORATION COMMON STOCK DURING THE PERIOD DECEMBER 9, 2004, THROUGH APRIL 28, 2005, INCLUSIVE.

YOU ARE HEREBY NOTIFIED that the above-captioned action has been certified as a class action and that a settlement for Six Million Dollars ($6,000,000) has been proposed. A hearing will be held before the Honorable Marvin J. Garbis in the United States District Court for the District of Maryland, United States Courthouse, 101 W. Lombard Street, Baltimore, MD 21201, at 10:00 a.m., on April 4, 2008, to determine whether (1) the proposed Settlement should be approved by the Court as fair, reasonable, and adequate; (2) Plaintiffs' Co-Lead Counsel's application for an award of attorneys' fees and reimbursement of expenses should be approved; (3) Lead Plaintiffs should be reimbursed for their reasonable costs and expenses (including lost wages) directly related to their representation of the Class in the litigation; and (4) the claims against the Defendants should be dismissed with prejudice.

IF YOU ARE A MEMBER OF THE CLASS DESCRIBED ABOVE, YOUR RIGHTS WILL BE AFFECTED AND YOU MAY BE ENTITLED TO SHARE IN THE SETTLEMENT FUND. If you have not yet received the full printed Notice of Proposed Settlement of Class Action and Motion for Attorneys' Fees and Expenses (the "Settlement Notice") and Proof of Claim and Release form ("Claim Form"), you may obtain copies of these documents by visiting MartekSecuritiesSettlement.com or by contacting:

Martek Biosciences Corp. Securities Litigation

Claims Administrator

c/o A.B. Data, Ltd.

Post Office Box 170500

Milwaukee, WI 53217

(866) 963-9978

Inquiries, other than requests for copies of the Settlement Notice and Claim Form, may be made to Plaintiffs' Co-Lead Counsel:

Katharine M. Ryan, Esq.

Schiffrin Barroway Topaz & Kessler, LLP

280 King of Prussia Road

Radnor, PA 19087

Janine L. Pollack, Esq.

Todd S. Kussin, Esq.

Milberg Weiss LLP

One Pennsylvania Plaza

New York, NY 10119

To participate in the Settlement, you must submit a Claim Form no later than May 15, 2008. If you are a member of the Class and do not submit a proper Claim Form, you will not share in the Settlement but you nevertheless will be bound by the Final Judgment and Order of Dismissal of the Court. As more fully described in the Settlement Notice, the deadline for submitting objections and requests for exclusion is March 21, 2008.

Further information may also be obtained by directing your inquiry in writing to the Claims Administrator, A.B. Data, Ltd., at the address listed above or call toll free (866) 963-9978.

By Order of The Court


'/>"/>
SOURCE Schiffrin Barroway Topaz & Kessler, LLP
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion
2. Summary Notice of Class Action in Re McKesson HBOC, Inc. Securities Litigation
3. Par Pharmaceutical Provides Summary of Analyst/Investor Day
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Putting the Medical Profession on Notice!: Widow Tells Tragic Story of How Her Husband Died Due to Misdiagnosis and Mistreatment
6. Melanomas may appear noticeably different than other moles
7. Medifast Receives Notice Regarding NYSE Listing
8. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
9. Innocoll Receives Intends to Grant Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology
10. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
11. Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdaq
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology: